Suspended KEMSA boss Manjari fails to appear before Senate team for allegedly been sick

 222 total views,  2 views today

BY NAMULONGO PETER,NAIROBI,21ST AUG 2020-The Kenya Medical Supplies Agency (KEMSA) CEO Dr. Jonah M Manjari is undergoing treatment at the Kenyatta National Hospital, a statement from the hospital has said.

The hospital  said Dr.Manjari was admitted on Thursday and is receiving treatment in Ward 9B.

Consequently, Senate Ad Hoc Committee on COVID-19 co.chaired by Senator Michael Mbito and Senator Kasanga adjourned a sitting in which Dr. Manjari was supposed to appear for grilling.

The CEO is expected to explain an alleged misappropriation of funds and irregularities in the procurement process of KEMSA medical equipment where it’s alleged that a double pricing from suppliers which led to a Ksh. 7.7 B loss of public funds

The latest comes just a day after foreign donors threatened to withdraw funding following a round of recent COVID-19 funds scandal.

Two key donors have threatened to withdraw up to Ksh.400 billion earmarked for Kenya following the latest COVID-19 scandal linked to a government agency.

Afya house has been in the news in the recent days with accusation of misappropriations of funds meant for purchasing PPEs and other COVID19 supplies being leveled against some seniors staff working with the ministry of health.Health ministry officials lead by CS Mutahi Kagwe

For weeks now, the rot at Afya house has refused to leave the headlines, with every ugly twist and turn of the COVID-19 scandal and even donors have been taking note.

The COVID-19 scandal has also created an internal crisis at the supplies agency: it stands to lose up to Ksh.2billion as it struggles to dispose of PPEs and other COVID-19 supplies.

KEMSA has been on the headlines for weeks now over allegations of graft and misappropriation of funds.

KEMSA is said to be unable to find buyers for the items that were allegedly purchased at inflated prices and now many of them could be about to hit their expert dates.

Sources within the board indicate that the agency is holding a stockpile worth over Ksh.6 billion.

The Board is seeking a green light from the Health Ministry to sell off the stock at market value of around Ksh.4billion to recoup its initial capital.

Sources further indicate that the Board is seeking a re-capitalization of Ksh.5billion to cushion itself from the loss that would have been occasioned by such a write off should the Health Cabinet Secretary agree to it.

The medical supplies authority is in a financial hole with a liability of over Ksh.8 billion, out of which Ksh. 5billion was already committed.

The Board attributes the mess to the procurements that were allegedly done without its approval or that of the Health Ministry.

Documents seen by Citizen TV indicate that at the onset of COVID-19 in Kenya, Health Ministry PS Susan Mochache directed that KEMSA procure 25,000 PPEs, 10,000 N95 masks and 6,000 lab sample transport collection consumable kits.

The directive was issued on March 18, 2020 and the next day after a meeting with the COVID-

Facebook Comments Box